CG
ABBV icon

Curat Global’s AbbVie ABBV Stock Holding History

Curat Global’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Sell
5,380
-387
-7% -$83.3K 1.18% 19
2026
Q1 		$1.25M Buy
5,767
+1,796
+45% +$398K 1.24% 16
2025
Q4 		$907K Sell
3,971
-2,478
-38% -$564K 1.01% 20
2025
Q3 		$1.49M Buy
6,449
+2
+0% +$407 1.4% 14
2025
Q2 		$1.2M Buy
6,447
+1,875
+41% +$348K 1.14% 19
2025
Q1 		$958K Buy
+4,572
New +$889K 1.17% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Curat Global's ABBV Position: Q2 2026 in Review

Curat Global reduced its AbbVie (ABBV) stake by 6.7% in Q2 2026, selling an estimated $83.3K and leaving 5,380 shares worth $1.44M. The position accounts for 1.18% of the portfolio, ranked #19.

Curat Global first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.49M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Curat Global held 5,380 shares of AbbVie worth $1.44M as of Q2 2026.
  • Curat Global sold 387 AbbVie shares in Q2 2026, an estimated $83.3K.
  • AbbVie made up 1.18% of Curat Global's portfolio in Q2 2026, its #19 holding.
  • Curat Global first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Curat Global's AbbVie position peaked at $1.49M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.